37138318|t|The G51D SNCA mutation generates a slowly progressive alpha-synuclein strain in early-onset Parkinson's disease.
37138318|a|Unique strains of alpha-synuclein aggregates have been postulated to underlie the spectrum of clinical and pathological presentations seen across the synucleinopathies. Whereas multiple system atrophy (MSA) is associated with a predominance of oligodendroglial alpha-synuclein inclusions, alpha-synuclein aggregates in Parkinson's disease (PD) preferentially accumulate in neurons. The G51D mutation in the SNCA gene encoding alpha-synuclein causes an aggressive, early-onset form of PD that exhibits clinical and neuropathological traits reminiscent of both PD and MSA. To assess the strain characteristics of G51D PD alpha-synuclein aggregates, we performed propagation studies in M83 transgenic mice by intracerebrally inoculating patient brain extracts. The properties of the induced alpha-synuclein aggregates in the brains of injected mice were examined using immunohistochemistry, a conformational stability assay, and by performing alpha-synuclein seed amplification assays. Unlike MSA-injected mice, which developed a progressive motor phenotype, G51D PD-inoculated animals remained free of overt neurological illness for up to 18 months post-inoculation. However, a subclinical synucleinopathy was present in G51D PD-inoculated mice, characterized by the accumulation of alpha-synuclein aggregates in restricted regions of the brain. The induced alpha-synuclein aggregates in G51D PD-injected mice exhibited distinct properties in a seed amplification assay and were much more stable than those present in mice injected with MSA extract, which mirrored the differences observed between human MSA and G51D PD brain samples. These results suggest that the G51D SNCA mutation specifies the formation of a slowly propagating alpha-synuclein strain that more closely resembles alpha-synuclein aggregates associated with PD than MSA.
37138318	4	8	G51D	ProteinMutation	tmVar:p|SUB|G|51|D;HGVS:p.G51D;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:431905511;CorrespondingSpecies:10090;CA#:267501
37138318	9	13	SNCA	Gene	6622
37138318	54	69	alpha-synuclein	Gene	6622
37138318	92	111	Parkinson's disease	Disease	MESH:D010300
37138318	131	146	alpha-synuclein	Gene	6622
37138318	263	280	synucleinopathies	Disease	MESH:D000080874
37138318	290	313	multiple system atrophy	Disease	MESH:D019578
37138318	315	318	MSA	Disease	MESH:D019578
37138318	374	389	alpha-synuclein	Gene	6622
37138318	402	417	alpha-synuclein	Gene	6622
37138318	432	451	Parkinson's disease	Disease	MESH:D010300
37138318	453	455	PD	Disease	MESH:D010300
37138318	499	503	G51D	ProteinMutation	tmVar:p|SUB|G|51|D;HGVS:p.G51D;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:431905511;CorrespondingSpecies:10090;CA#:267501
37138318	520	524	SNCA	Gene	6622
37138318	539	554	alpha-synuclein	Gene	6622
37138318	597	599	PD	Disease	MESH:D010300
37138318	672	674	PD	Disease	MESH:D010300
37138318	679	682	MSA	Disease	MESH:D019578
37138318	724	731	G51D PD	CellLine	CVCL:LE55
37138318	732	747	alpha-synuclein	Gene	20617
37138318	811	815	mice	Species	10090
37138318	847	854	patient	Species	9606
37138318	901	916	alpha-synuclein	Gene	20617
37138318	954	958	mice	Species	10090
37138318	1053	1068	alpha-synuclein	Gene	20617
37138318	1103	1106	MSA	Disease	MESH:D019578
37138318	1116	1120	mice	Species	10090
37138318	1169	1176	G51D PD	CellLine	CVCL:LE55
37138318	1219	1239	neurological illness	Disease	MESH:D009461
37138318	1301	1316	synucleinopathy	Disease	MESH:D000080874
37138318	1332	1339	G51D PD	CellLine	CVCL:LE55
37138318	1351	1355	mice	Species	10090
37138318	1394	1409	alpha-synuclein	Gene	20617
37138318	1469	1484	alpha-synuclein	Gene	20617
37138318	1499	1506	G51D PD	CellLine	CVCL:LE55
37138318	1516	1520	mice	Species	10090
37138318	1629	1633	mice	Species	10090
37138318	1648	1651	MSA	Disease	MESH:D019578
37138318	1709	1714	human	Species	9606
37138318	1715	1718	MSA	Disease	MESH:D019578
37138318	1723	1730	G51D PD	CellLine	CVCL:LE55
37138318	1777	1781	G51D	ProteinMutation	tmVar:p|SUB|G|51|D;HGVS:p.G51D;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:431905511;CorrespondingSpecies:10090;CA#:267501
37138318	1782	1786	SNCA	Gene	6622
37138318	1844	1859	alpha-synuclein	Gene	6622
37138318	1895	1910	alpha-synuclein	Gene	6622
37138318	1938	1940	PD	Disease	MESH:D010300
37138318	1946	1949	MSA	Disease	MESH:D019578
37138318	Positive_Correlation	MESH:D010300	RS#:431905511;HGVS:p.G51D;CorrespondingGene:6622
37138318	Association	MESH:D010300	20617
37138318	Association	MESH:D019578	RS#:431905511;HGVS:p.G51D;CorrespondingGene:6622
37138318	Association	MESH:D010300	6622
37138318	Association	MESH:D019578	6622
37138318	Association	MESH:D000080874	6622
37138318	Association	MESH:D000080874	20617

